LBX Pharmacy Chain Joint Stock Company (SHA:603883)

China · Delayed Price · Currency is CNY

12.95

+0.14 (1.09%)

Aug 3, 2026, 3:00 PM CST

-32.59% (1Y)

Market Cap	9.83B -32.7%
Revenue (ttm)	22.28B +0.1%
Net Income	395.07M -11.9%
EPS	0.52 -11.9%
Shares Out	758.89M
PE Ratio	24.99
Forward PE	17.01
Dividend	0.41 (3.20%)
Ex-Dividend Date	Jul 3, 2026

Volume	9,400,037
Open	12.75
Previous Close	12.81
Day's Range	12.73 - 13.02
52-Week Range	10.67 - 20.03
Beta	0.43
Analysts	Buy
Price Target	18.24 (+40.85%)
Earnings Date	Aug 28, 2026

About SHA:603883

LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The company is also involved in wholesale and retail of pharmaceutical products; Chinese medicine research and development; e-commerce; food and departmen... [Read more]

Industry Pharmaceutical Retailers

Sector Healthcare

Founded 2001

Employees 36,892

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603883

Full Company Profile

Financial Performance

In 2025, SHA:603883's revenue was 22.24 billion, a decrease of -0.54% compared to the previous year's 22.36 billion. Earnings were 381.85 million, a decrease of -26.44%.

Financial Statements

Analyst Summary

According to 13 analysts, the average rating for 603883 stock is "Buy." The 12-month stock price target is ¥18.24, which is an increase of 40.85% from the latest price.

Price Target

¥18.24

(40.85% upside)

Analyst Consensus: Buy

Stock Forecasts